GR1008305B - Drinkable pharmaceutical solutions containing glycocorticosteroids - Google Patents

Drinkable pharmaceutical solutions containing glycocorticosteroids

Info

Publication number
GR1008305B
GR1008305B GR20130100299A GR20130100299A GR1008305B GR 1008305 B GR1008305 B GR 1008305B GR 20130100299 A GR20130100299 A GR 20130100299A GR 20130100299 A GR20130100299 A GR 20130100299A GR 1008305 B GR1008305 B GR 1008305B
Authority
GR
Greece
Prior art keywords
solutions containing
glycocorticosteroids
pharmaceutical solutions
drinkable pharmaceutical
drinkable
Prior art date
Application number
GR20130100299A
Other languages
Greek (el)
Inventor
Ηλιας Ιωαννη Κοτσιανης
Αγγελος Αντωνιου Καρατζας
Original Assignee
Λαμδα Φαρμακευτικη Α.Ε.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Λαμδα Φαρμακευτικη Α.Ε., filed Critical Λαμδα Φαρμακευτικη Α.Ε.,
Priority to GR20130100299A priority Critical patent/GR1008305B/en
Publication of GR1008305B publication Critical patent/GR1008305B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Drinkable pharmaceutical solutions containing dexamethasone sodium phosphate as drastic component and one aqueous carrier composed of propylenoglycol and a buffer. Although free of ethanol, the solutions of the present invention exhibit excellent stability.
GR20130100299A 2013-05-17 2013-05-17 Drinkable pharmaceutical solutions containing glycocorticosteroids GR1008305B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20130100299A GR1008305B (en) 2013-05-17 2013-05-17 Drinkable pharmaceutical solutions containing glycocorticosteroids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20130100299A GR1008305B (en) 2013-05-17 2013-05-17 Drinkable pharmaceutical solutions containing glycocorticosteroids

Publications (1)

Publication Number Publication Date
GR1008305B true GR1008305B (en) 2014-09-25

Family

ID=49510115

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20130100299A GR1008305B (en) 2013-05-17 2013-05-17 Drinkable pharmaceutical solutions containing glycocorticosteroids

Country Status (1)

Country Link
GR (1) GR1008305B (en)

Similar Documents

Publication Publication Date Title
PH12018500894A1 (en) Aqueous pharmaceutical formulation comprising anti-pd-l1 antibody avelumab
EA201991715A1 (en) COMPOSITIONS CONTAINING AN ANTIBODY TO PDL1
MX2016003843A (en) Irak inhibitors and uses thereof.
MX362582B (en) Fused tricyclic urea compounds as raf kinase and/or raf kinase dimer inhibitors.
PH12016501122A1 (en) Delayed release compositions of linaclotide
SG10201811017QA (en) Novel antibody frameworks
MX2020001756A (en) Benzoquinolone inhibitors of vmat2.
PH12016500720A1 (en) Stable formulation of insulin glulisine
UA118666C2 (en) Novel pyrazol derivatives
EP3060229A4 (en) Stable, aqueous antibody formulations
MX2015010106A (en) Flap modulators.
MX367210B (en) Stable oral solutions for combined api.
PH12017501280B1 (en) Hydroxyalkyl-piperazine derivatives as cxcr3 receptor modulators
MX2016008369A (en) Pharmaceutical composition containing palonosetron.
AU2018253594A1 (en) Dihydroxyphenyl neurotransmitter compounds, compositions and methods
IN2013MU03641A (en)
MX2016014179A (en) Pharmacologically active quinazolinedione derivatives.
MX2017009292A (en) (r)-2-methyl-piperazine derivatives as cxcr3 receptor modulators.
TW201613640A (en) Stable aqueous adalimumab preparation
MX2015016603A (en) Corticosteroid compositions.
MX363458B (en) Novel tetrazolone derivatives.
MX2016006807A (en) Imidazole derivatives.
EP3083661A4 (en) Cap260, cap174 and k0224 hiv-1 envelopes, peptide and compositions
GR1008305B (en) Drinkable pharmaceutical solutions containing glycocorticosteroids
IN2013CH00453A (en)

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20141017